Exelixis EXEL
NASDAQ EXEL
$58.65 +0.28 (+0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

Exelixis (EXEL) Construction in Progress (2010 - 2017)

Updated

Exelixis' Construction in Progress was $14.5 million in Q2 2017.

Analysis

Exelixis (EXEL) Construction in Progress (2010 - 2017) Analysis & Trends

At the end of FY2015, Construction in Progress at Exelixis came in at $456,000, up 280.0% from FY2014.

  • Construction in Progress shows a five-year compound annual growth rate of 4.1% (FY2010 to FY2015).
  • In earlier years, Construction in Progress was $120,000 in FY2014 (+76.5%), $68,000 in FY2013 (-95.2%), $1.41 million in FY2012 (+809.0%) and $155,000 in FY2011 (-58.4%).
  • The Q2 2017 figure marks the lowest quarterly Construction in Progress since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Exelixis 14.53 Bn 10.86 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 14.50 Mn
Dec 31, 2015 456,000.00
Dec 31, 2014 120,000.00
Dec 31, 2013 68,000.00
Dec 31, 2012 1.41 Mn
Dec 31, 2011 155,000.00
Dec 31, 2010 373,000.00
API Access

Exelixis Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=EXEL&period=max&api_key=YOUR_API_KEY